Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Breyer

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Cell Metabolism|September 13, 2005
Getting to the heart of COX-2 inhibitionMatthew D Breyer
Contributions to Nephrology|June 11, 2011
Translating experimental diabetic nephropathy studies from mice to menMatthew D Breyer
Diabetes|June 20, 2024
AKR1A1 and Kidney Disease: Promise and Perils of the MultiverseMatthew D Breyer
Journal of the American Society of Nephrology : JASN|August 14, 2010
Progress in progression?Matthew D Breyer
Expert Opinion on Drug Discovery|December 17, 2013
Improving productivity of modern-day drug discoveryMatthew D Breyer
Seminars in Nephrology|April 10, 2007
Diabetic nephropathy: introductionMatthew D Breyer
Kidney International|October 10, 2002
Beyond cyclooxygenaseMatthew D Breyer
Journal of the American Society of Nephrology : JASN|August 8, 2008
Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal modelMatthew D Breyer
Seminars in Nephrology|October 16, 2012
Drug discovery for diabetic nephropathy: trying the leap from mouse to manMatthew D Breyer
Seminars in Nephrology|December 19, 2016
Developing Treatments for Chronic Kidney Disease in the 21st CenturyMatthew D Breyer, Katalin Susztak
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Cell Metabolism|September 13, 2005
Getting to the heart of COX-2 inhibitionMatthew D Breyer
Contributions to Nephrology|June 11, 2011
Translating experimental diabetic nephropathy studies from mice to menMatthew D Breyer
Diabetes|June 20, 2024
AKR1A1 and Kidney Disease: Promise and Perils of the MultiverseMatthew D Breyer
Journal of the American Society of Nephrology : JASN|August 14, 2010
Progress in progression?Matthew D Breyer
Expert Opinion on Drug Discovery|December 17, 2013
Improving productivity of modern-day drug discoveryMatthew D Breyer
Seminars in Nephrology|April 10, 2007
Diabetic nephropathy: introductionMatthew D Breyer
Kidney International|October 10, 2002
Beyond cyclooxygenaseMatthew D Breyer
Journal of the American Society of Nephrology : JASN|August 8, 2008
Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal modelMatthew D Breyer
Seminars in Nephrology|October 16, 2012
Drug discovery for diabetic nephropathy: trying the leap from mouse to manMatthew D Breyer
Seminars in Nephrology|December 19, 2016
Developing Treatments for Chronic Kidney Disease in the 21st CenturyMatthew D Breyer, Katalin Susztak
Pageof 13